Restoring continence in frail older people living in the community: what factors influence successful treatment outcomes?
SIR-The prevalence of urinary incontinence (UI) in frail older people is high, yet it is often overlooked, and if identified, poorly assessed and managed conservatively [1] [2] [3] [4] [5] [6] by pad provision [3] or catheterisation [7] . Providers generally perceive low potential for restoring continence in frail older people. There are few studies of UI management and outcomes in home-dwelling frail older people. A 2-month RCT of oxybutynin and bladder retraining improved urinary frequency but not UI [8] . Another study concluded that after 4 weeks of oxybutynin for urge UI, impaired cognition, cerebrovascular disease and reduced bladder sensation predicted poor efficacy [9] . A study of fitter women (aged 40-92) found UI severity predicted persistence following behavioural treatment, while age, UI type and co-morbidities were unassociated [10] . Prompted voiding can reduce UI in cognitively impaired housebound people [11, 12] , with cognition and function influencing outcome [12, 13] . CGA has been recommended (though not researched) for promoting continence by addressing related co-morbidities and medications [6] .
Method
The study aims are to test the hypotheses that (i) UI in frail home-dwelling older people can be resolved or improved in a substantial proportion using a structured CGA-based approach and (ii) certain case-mix and bladder/bowel characteristics are associated with poorer treatment outcome. The setting is a bladder/bowel continence clinic for patients aged 65+ within the geriatric department of a large urban teaching hospital. Subjects were new patients with UI seen between January 2004 and January 2007. Exclusion criteria were (i) patients not reviewed within 4-months of index visit or (ii) clinic letters unobtainable. Referrals came from the acute inpatient service (38%, seen post-discharge), medical clinics, stroke service, A&E, and community. The clinic was undertaken by a consultant geriatrician and continence nurse specialist, with doctor and nurse trainees. This is a retrospective cohort study with data abstraction from clinical letters by an independent nurse researcher and informed geriatrician. Patients were generally reviewed 6 weeks and 3-4 months after the index visit; the last postindex visit within 4 months was used for follow-up data collection. Use of a structured clinical pro forma meant letters were strictly formatted. UI frequency was measured as 'never', 'rarely' (less than once in a week), 'sometimes' (two to three times a week), 'daily' by patient and/or carer's selfreport. UI at follow-up was characterised as 'resolved', 'better', 'same' and 'worse' based on the recorded frequency. Specific bladder/bowel symptoms were similarly characterised. Data analysis was done using chi-square, relative risk and multiple logistic regression analysis.
Management was evidence based:

Continence assessment
Diagnoses were based on symptoms, voiding chart, clinical examination and post-void residual volume (PVRV) by hand-held bladder scan (without urodynamics as per NICE guidelines) [1, 6, 14, 15] .
Non-pharmacological treatment
Pelvic floor exercises (PFE) and bladder retraining are firstline treatment in women with stress, urge or mixed UI [6, 15] and effective in older women [10, 16] . PFE were taught by verbal feedback during vaginal palpation, an effective method in older women [16] . Gender-specific handouts and telephone reinforcement at 2 and 4 weeks post-index visit were given. Other non-pharmacological interventions were caffeine reduction [15, 17] , constipation management [18, 19, 20] and fluid advice [6] . Prompted voiding [11, 12] (carer instructions and individualised care plans) was used where cognitive impairment was a primary cause of UI.
Antimuscarinic medications
Antimuscarinic medications were prescribed for urge or mixed UI only after thorough assessment for co-morbid factors, and when non-pharmacological interventions failed to achieve continence goals [6] . They were combined with PFE/bladder retraining (combination treatment is more effective than drugs alone in older people) [21, 22] . Tolterodine is well tolerated in frailer older people [22] , and can be effective at lower doses (1 mg once or twice daily) [23] , which were always used in dementia, Parkinson's disease and postural hypotension to reduce risk of cognitive changes and falls [2, 23] . All patients given antimuscarinics had PVRV follow-up [6] .
Other pharmacological treatment
Atrophic vaginitis and urinary tract infections (UTIs) are risk factors for UI in postmenopausal women [5, 24] . Vaginal oestrogen improves mucosal integrity [25] and reduces recurrent UTIs [26] . Bacteruria was treated if associated with pyuria [27] . Symptomatic benign prostatism was treated with α-blockers, plus finasteride for persistent symptoms and/or large prostatic volume.
Comprehensive geriatric assessment
CGA focussed on modifying factors outside the urinary tract that may influence continence:
r Optimising medical conditions, e.g. heart failure (nocturia, diuretic effect), COPD (stress UI exacerbated by cough/wheeze), diabetes (polyuria, candidiasis, UTI) r Improving toilet access and physical function [4, 5] r Adjusting pertinent medications [4] and/or improving compliance r Involving patients and carers in goal setting and followthrough. Table 1 demonstrates the age and frailty of the 112 study subjects. Thirty per cent had cognitive impairment, but UI was attributable to dementia as primary cause in only three individuals. Most (64%) subjects had severe (daily) incontinence. The predominant diagnosis was overactive bladder with urge UI. Stress UI usually co-existed with urge UI ('mixed UI'). Seventy per cent had nocturia (sleep disturbed more than two Index data were complete except for living alone (missing = 28), duration of UI (missing = 32) and PVRV amount (missing = 35).
Results
times). Vaginal prolapse (usually stages 1-11) and demonstrable atrophic vaginitis were common. Half had symptoms of constipation, 28% rectal impaction and 18% faecal incontinence. While 70% of patients received PFE/bladder retraining, only 38% were prescribed antimuscarinics. Few were managed primarily by prompted toileting. Medication changes (mainly diuretics, anticholinergics, α-blockers) and continence-related disease management occurred in over a third. Treatment non-adherence was documented in 12 (11%) subjects, 4 of whom had dementia. Six people were unable to do behavioural treatment and six did not comply with or tolerate antimuscarinics.
Mean period between the index visit and follow-up was 2.4 ± 0.9 months. UI at follow-up was resolved in 23.2% (26) , improved in 44.6% (50), unchanged in 29.5% (33) and worse in 2.7% (3). Of those 32% with persistent UI, only one-third reported daily leakage. More people with urge UI than stress UI reported improvement. Nocturia persisted in 43% (38% reduction). Two-thirds of patients with faecal incontinence reported improvement.
Factors univariately associated with persistent UI (n = 35) versus resolved/better UI (n = 77) were age 80+, poor mobility, dementia, daily UI, recurrent UTI, neuropathic bladder and rectal impaction (see Appendix 1 available on Age and Ageing online). People with persistent UI were less likely to have received bladder retraining, but more likely to be managed by prompted toileting, and to have continence-related medication changes. Independent associations from multivariate analysis were age 80 and over (AOR 2.56, 95% CI 1.1-6.3), daily UI (AOR 3.33, 95% CI 1.2-9.3) and recurrent UTI (AOR 2.18, 95% CI 0.9-5.3).
Discussion
These findings showed good therapeutic responses within 4 months (dryness restored in 23% and UI improved in 45%) in a frail elderly outpatient population with high co-morbidities. Advanced age, incontinence severity at presentation and recurrent UTI were independently associated with poorer treatment outcome, while co-morbidities such as dementia, stroke, reduced mobility and falls were not.
Guidelines strongly recommend non-pharmacological treatments in older people [6, 15] and only 38% in this study required antimuscarinics. Behavioural treatment for urge UI can positively affect psychological distress in older women, more than drugs alone [28] . We found that even frail older people can comply with PFEs and bladder retraining. Subjects living alone tended towards poorer outcome, possibly reflecting the value of informal carers in reinforcement and encouragement.
The association of advanced age with poorer response suggests that age-related changes are important. Aged bladder electron microscopy shows dysjunction patterns and muscle/axonal degeneration, which can affect function by decreasing capacity and contractility, and increasing involuntary detrusor contractions [6] . Lower urethral closure pressure in older women and prostatic hypertrophy in older men increase likelihood of UI. Increased nighttime urine production causes nocturia, a symptom which proved most resistant in these frailer individuals.
The relationship between daily UI at presentation and poorer outcome suggests that UI severity indicates lower urinary tract dysfunction [10] , though in these complex patients frailty can also contribute to UI frequency [14] . UTIs increase UI incidence in older people [5] . Our findings linked recurrent UTIs to UI persistence, possible mechanisms being age related (altered immunity, reduced oestrogen) and frailty (UTI is a national health frailty indicator for older inpatients) [29] .
We found that the univariate relationships with poor mobility, dementia and falls were largely confounded by advanced age and not independently significant. Clinically however, these conditions can impact treatment, e.g. restricting use of antimuscarinic or α-blockers or reducing adherence to behavioural measures. Conversely, urinary urgency increases falls risk, especially at night [14] , but whether managing incontinence in fallers reduces falls incidence needs further exploration [30] .
Rectal impaction at presentation was univariately linked to persistent UI, probably through shared pathophysiological and clinical mechanisms [20] . Constipation quadruples risk of urinary retention in older hospitalised women [19] . Improving constipation symptoms can improve co-existing urinary symptoms and reduce PVRVs and UTIs [18] .
Pressure ulcers, falls, functional decline, delirium and incontinence are inter-linked, and addressing all these and their shared risk factors promotes successful treatment [30] . One-third of patients had medications or disease modifications to improve continence, reflecting the CGA process. This study was limited in not randomising prospectively to compare natural history versus treatment, though once UI is identified such methodology is ethically questionable. An RCT examining additional benefit of CGA in continence management is however feasible, including longer term outcomes and adherence.
This study described a standardised, low-intensity (generally two clinic visits and two phone calls), and hence a generalisable approach. Currently however, the importance of treating incontinence in frail older people is widely underestimated in the UK. Major deficits to delivering integrated continence care to older people have been highlighted in a recent national audit [1] , including limited resourcing of continence nurse specialists (presently 1 : 40,000 people aged 65+) [1] .
In conclusion, expectations among both frail older people with UI and their providers of regaining dryness are often low. This study suggests that CGA-linked continence management can be effective in the context of frailty and chronic disease, though advanced age and UI severity may impact successful treatment outcomes.
Key points
r The prevalence of UI in home-dwelling frail older people is high, yet the condition is often overlooked, and if identified, frequently managed conservatively. r This study indicates that continence treatment in older people can be effective (continence restored in 23% and improved in 45%) in context of frailty and chronic disease using a feasible evidence-based CGA approach. r Poorer treatment outcomes are associated with advanced age, severity of incontinence and recurrent UTI, but not with co-morbidities such as dementia, stroke, reduced mobility and falls.
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Supplementary data are available at Age and Ageing online. Advancing age is not a reason to withhold ERCP SIR-Endosocopic retrograde cholangiopancreatography (ERCP) provides an attractive less invasive alternative to surgery for the management of biliary and pancreatic disease [1] . However, the presence of comorbidities in elderly patients places them at increased risk undergoing such an invasive procedure. It would appear that ERCP is being increasingly required in the elderly because of the rising life expectancy and the increased incidence of biliary tract and pancreatic pathology in this population [2, 3] . The studies to date report that ERCP in the elderly is not only safe but also associated with a high biliary cannulation rate [4, 5] . However, these studies have certain limitations in that not all have been comparative, some have examined only a small number of patients while others have not analysed outcomes in very elderly patients. We performed a retrospective case control study to determine if the incidence of ERCP in the elderly is rising and to compare the outcomes of this procedure in a large number of patients at least 80 years of age with a younger population.
Methods
We identified an elderly and a younger group from a prospectively maintained single centre ERCP database. The elderly group included all patients over the age of 80 years (mean age 85 years, range 80.0-100.8 years, 55% female, 45% male). The younger group was computer selected from patients under the age of 55 years.
This group was matched for sex (55% female, 45% male), contained a similar number of patients as and had a mean age 40 years less than the elderly group (mean age 45 years, range 32.7-54.9 years).
We looked at the annual incidence of ERCP performed in the elderly population over this 9-year period and compared procedure outcomes in terms of technical difficulty and safety to the younger group.
The results of repeat procedures in those patients who had more than one ERCP were excluded.
The technical difficulty of the procedure was analysed through parameters including successful bile duct cannulation, need for needle knife fistulotomy for bile duct access, the sphincterotomy rate and finally whether biliary tract stones were successfully extracted or stent insertion was required for biliary drainage. The safety of the procedure was determined by the risk of complications including the mortality rate. Bleeding was classified as mild when it settled spontaneously, as moderate when tamponade injection with adrenaline in saline was required for haemostasis and as severe when blood transfusion was needed.
The chi-square test was used to analyse the results. P values < 0.05 were considered to be statistically significant.
Results
A total of 3,150 ERCP procedures have been performed at our institution from July 1998 to July 2007. Of these patients, 573 (18.2%) were found to be more than 80 years old. The younger group included 571 patients. A total of 34 (15.7%) ERCPs were performed in the elderly group in 1998. This rose to 103 (23.3%) in 2007 resulting in a significant increase of 48.4% in the number of ERCPs performed in the elderly over this 9-year period (P < 0.02). Data from the central statistics office show that the total population over the age of 80 years has increased by 25.8% over the same time period (Figure 1 ).
Bile duct cannulation was successful in 91.8% of elderly patients. This was not significantly different to a cannulation rate of 92.5% in the control patients. The need for fistulotomy for bile duct access was greater in the elderly patients (17.7% vs. 10.5%, P < 0.001). A total of 7.8% of elderly and 25.9% of younger patients were found to have a normal ERCP. Following exclusion of these patients, we found that there was no difference in the endoscopic sphincterotomy rate between the two groups (96.7% in the elderly vs. 97.2% in the younger group). Please see Appendix 1 (available on Age and Ageing online).
The incidence of choledocholithiasis was significantly higher in the elderly group (60.8% vs. 53%, P <0.02). Definitive treatment of biliary tract stone disease was more effective in the control group. This was reflected in a higher incidence of successful stone extraction (74.0% vs. 41.5%, P < 0.0001) and a lower incidence of plastic stent insertion for biliary drainage in this group (26.0% vs. 48.5%, P < 0.0001). Malignant biliary strictures including cholangiocarcinoma and pancreatic cancer were significantly higher in the elderly group (19.9% vs. 6.3%, P < 0.0001). Metal stenting of these strictures was also higher in this group (78.0% vs. 18.0%, P < 0.0001). Please see Appendix 2 (available on Age and Ageing online).
There were no complications in those patients who had a failed or a normal procedure. Hence the complication rate was based solely on therapeutic ERCPs. There was no significant difference in the complication rate between the two groups (1.6% in the elderly group and 2.0% in the younger group). There were no deaths in either group (Table 1) .
